Ulcerative Colitis Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

September 13 21:15 2021
Ulcerative Colitis Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight
DelveInsight Business Research LLP
DelveInsight’s “Ulcerative Colitis (UC) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Ulcerative Colitis (UC), historical and forecasted epidemiology as well as the Ulcerative Colitis (UC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Ulcerative Colitis – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Ulcerative Colitis – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Ulcerative Colitis, historical and forecasted epidemiology as well as the  Ulcerative Colitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. The total prevalent population of Ulcerative Colitis in the 7MM in 2020 was 2,201,831. These cases are expected to rise by 2030, during the forecast period [2021–2030]. 

  2. According to DelveInsight’s analysis, in the 7MM, the United States reported the highest prevalent cases of Ulcerative Colitis, i.e., 1,008,823 which accounted for nearly 46% of the total 7MM cases, in the year 2020. 

  3. Among the EU-5 countries, the highest number of cases of Ulcerative Colitis was in Germany, i.e., 342,785 cases in the year 2020. 

Key benefits of the report:

  1. Ulcerative Colitis market report covers a descriptive overview and comprehensive insight of the Ulcerative Colitis epidemiology and Ulcerative Colitis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

  2. The Ulcerative Colitis market report provides insights on the current and emerging therapies.

  3. Ulcerative Colitis market report provides a global historical and forecasted market covering drug outreach in 7MM.

  4. The Ulcerative Colitis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Ulcerative Colitis market.

Got queries? Click here to know more about Ulcerative Colitis Market Landscape.

Ulcerative Colitis Overview

Ulcerative colitis is usually only in the innermost lining of the large intestine (colon) and rectum. Forms range from mild to severe. Having ulcerative colitis puts a patient at increased risk of developing colon cancer.

The key players involved in the Ulcerative Colitis market:

  • AbbVie and Boehringer Ingelheim

  • Eli Lilly and Company

  • Janssen

  • Galapagos/Gilead

  • Theravance Biopharma and Janssen 

  • Arena

  • Landos Biopharma

  • And others

The launch of the emerging therapies is expected to significantly impact the Ulcerative Colitis treatment scenario in the upcoming years:-

Drug covered

  • Risankizumab (ABBV-066) 

  • Mirikizumab (LY3074828) 

  • Tremfya (Guselkumab) 

  • Filgotinib

  • Izencitinib (TD-1473)

  • Etrasimod (APD334) 

  • BT-11

  • And others.

Table of Contents

1. Report Introd Ulcerative Colitis

2. Executive Summary

3. SWOT analysis

4. Ulcerative Colitis Patient Share (%) Overview at a Glance

5. Ulcerative Colitis Market Overview at a Glance

6. Ulcerative Colitis Disease Background and Overview

7. Ulcerative Colitis Epidemiology and Patient Population

8. Country-Specific Patient Population of Ulcerative Colitis

9. Ulcerative Colitis Current Treatment and Medical Practices

10. Unmet Needs

11. Ulcerative Colitis Emerging Therapies

12. Ulcerative Colitis Market Outlook

13. Country-Wise Ulcerative Colitis Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Ulcerative Colitis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Ulcerative Colitis Pipeline 

“Ulcerative Colitis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Ulcerative Colitis market. A detailed picture of the Ulcerative Colitis pipeline landscape is provided, which includes the disease overview and Ulcerative Colitis treatment guidelines.

Ulcerative Colitis Epidemiology

DelveInsight’s ‘Ulcerative Colitis Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Ulcerative Colitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/dimapurnewsdesk/dehradunmail.in/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7